Usefulness of Information from the Unlinked Anonymous Prevalence Monitoring Programme for HIV in England and Wales: Survey of Planners of HIV/AIDS Services

Abstract

The aim of this study was to evaluate whether information from the Unlinked Anonymous Prevalence Monitoring Programme for HIV in England and Wales is useful to planners of HIV/AIDS services. The study involved 2 stages: examination of 1997 AIDS Control Act Reports for England and Wales, and a telephone questionnaire survey of local planners of HIV/AIDS services.

Forty-eight out of 55 health authorities (87.3%) found information from the programme to be useful in general; 37/55 (67.3%) found the information useful for targeting of health promotion; 35/55 (63.6%) found the information useful for assessing the effectiveness of preventive measures aimed at reducing the spread of HIV; and 28/55 (50.9%) found the information useful for planning of medical or social services. If information from the programme was no longer available, 36/55 (65.5%) said it would make some difference to local planning, although 12/55 (21.8%) said it would make no difference. Local planners were generally supportive of the programme, and complaints were mostly directed at funding and timeliness of the reports.

Keywords

HIV unlinked anonymous prevalence usefulness

Get full access to this article

View all access options for this article.

References

Gill

O.N.

, Adler

M.W.

, Day

N.E.

. Monitoring the prevalence of HIV. BMJ 1989; 299: 1295–8

Heptonstall

, Gill

O.N.

. The legal and ethical basis for unlinked anonymous HIV testing. Comm Dis Report (London, Public Health Laboratory Services) 1989; 48: 3–6

Communicable Disease Surveillance Centre, PHLS AIDS Centre, Central Public Health Laboratory Hepatitis and Retrovirus Laboratory, Virus Reference Division and PHLS Statistics Unit

PHLS AIDS Centre, PHLS Virus Reference Division, PHLS Statistics Unit, Academic Department of Genito-urinary Medicine University College and Middlesex School of Medicine, and Collaborators.

Unlinked anonymous monitoring of HIV prevalence in England and Wales; 1990-1992.

Comm Dis Report (London, Public Health Laboratory Services) 1993; 3: R1–R11

Gill

O.N.

, Adler

M.W.

, Day

N.E.

. Monitoring the prevalence of HIV. BMJ 1989; 299: 1297

Chin

. Public health surveillance of AIDS and HIV infections. Bull WHO 1990; 68: 529–36

Dondero

T.J.

. Large-scale HIV serologic surveys: what has been learned? AIDS 1991; 5(suppl.): S63–S69

Report of an Expert Group (Chairman: Professor NE Day) convened by the Director of the Public Health Laboratory Service on behalf of the Chief Medical Officers.

The incidence and prevalence of acquired immune deficiency syndrome and other severe HIV disease in England and Wales for 1992-1997: projections using data to the end of 1992.

Comm Dis Rep (London, Public Health Laboratory Services) 1993; 3(suppl. 1)

Report of an Expert Group convened by the Director of the Public Health Laboratory Service on behalf of the Chief Medical Officers.

The incidence and prevalence of AIDS and the prevalence of other severe HIV disease in England and Wales for 1995 to 1999: projections using data to the end of 1994.

Comm Dis Rep (London, Public Health Laboratory Services) 1996; 6: R1–R24

10.

Report from the Unlinked Anonymous Surveys Steering Group. Prevalence of HIV in England and Wales in 1997: Annual Report of the Unlinked Anonymous Prevalence Monitoring Programme. London: Department of Health (K12/004 14504 1P 3k), 1998: 9 [Adapted by the Surveys Steering Group from their own 1995 report and the 1991 Medical Research Council Strategic Review]

11.

Woodward

, Chambers

. Guide to Questionnaire Construction and Question Writing. Ottawa: Canadian Public Health Association, 1986

12.

Stone

. Design a questionnaire. BMJ 1993; 307: 1264–6

13.

Hennekens

C.H.

. Epidemiology in Medicine. Boston: Little, Brown and Company, 1987: 272–86.

14.

Seven individuals involved in planning of HIV/AIDS services at the national level were informally interviewed and were highly supportive of the programme; over half, however, declared an interest in the programme

15.

Kessel

A.S.

, Watts

C.J.

. Bad blood: survey of the public's views of unlinked anonymous testing of blood for HIV and other diseases. BMJ 1999 (in press)

16.

Bayer

, Lumey

, Lourdes

. The American, British and Dutch responses to unlinked anonymous HIV seroprevalence studies: an international comparison. AIDS 1990; 4: 283–90

17.

Kopelman

L.M.

. Informed consent and anonymous tissue samples: the case of HIV seroprevalence studies. J Med Philosophy 1994; 19: 525–52

18.

Kessel

A.S.

, Crawford

. Openness with patients: a categorical imperative to correct an imbalance. Science Engineering Ethics 1997; 3: 297–304